Creating a tool to predict how immune cells respond to RNA viruses
Developing a predictive in silico toolkit for modeling NK cell responses against RNA virus infections
This study is working on a computer tool to help us understand how special immune cells called Natural Killer (NK) cells respond to different RNA viruses like Dengue and Ebola, which could lead to better ways to treat and prevent these infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project ID | NIH-10686795 on NIH RePORTER |
What this research studies
This research focuses on developing a computational toolkit that models the responses of Natural Killer (NK) cells, which are crucial components of the innate immune system, to various RNA virus infections such as Dengue and Ebola. By using mathematical modeling, the project aims to better understand the complex signaling processes that activate NK cells, which do not rely on a single receptor like other immune cells. The goal is to enhance our knowledge of how these immune cells interact with viruses, potentially leading to improved treatments and preventive strategies for viral infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of or currently infected with RNA viruses such as Dengue or Ebola.
Not a fit: Patients with viral infections not involving RNA viruses or those with conditions unrelated to NK cell responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better strategies for enhancing immune responses against RNA viruses, improving patient outcomes.
How similar studies have performed: While the approach of modeling NK cell responses is innovative, similar mathematical modeling techniques have shown promise in understanding other immune responses, suggesting potential for success.
Where this research is happening
Columbus, United States
- Research Inst Nationwide Children's Hosp — Columbus, United States (Active)
Researchers
- Principal investigator: Das, Jayajit — Research Inst Nationwide Children's Hosp
- Study coordinator: Das, Jayajit
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.